Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Supramolecular Structure and Nuclear targeting efficiency Determine the Enhancement of Transfection by Modified Polylysines

Loading...
Thumbnail Image

Date

Authors

Chan, Chee Kai
Senden, Timothy
Jans, David A

Journal Title

Journal ISSN

Volume Title

Publisher

Nature Publishing Group

Abstract

Polylysine (ply) has been used as a DNA carrier in nonviral gene delivery systems because it forms complexes with plasmid DNA via charge interaction, and condenses it into a compact structure. We have recently shown that cross-linking nuclear localization sequences (NLSs) to ply can enhance transfection by conferring specific recognition by the cellular nuclear import 'receptor', the NLS-binding importin α/β heterodimer. The present study examines and correlates for the first time the effect of the lysine/nucleotide (Ly/Nu) ratio on transfection, recognition by importin α/β, and structure as determined using electron microscopy (EM) and atomic force microscopy (AFM), for ply-DNA complexes with and without NLSs or mutant versions thereof. Intriguingly, we observed two distinct peaks of transfection enhancement at Ly/Nu ratios of 0.4 and 4.0, attributable to specific NLS recognition by importins and DNA compaction, respectively. The results indicate a clear correlation between the ply-DNA structure, importin α/β recognition, and gene transfer efficiency, thus underlining the importance of using ply-DNA at the optimal Ly/Nu ratio.

Description

Citation

Source

Gene Therapy

Book Title

Entity type

Access Statement

License Rights

DOI

Restricted until

2037-12-31